Viracta Therapeutics, Inc. 8-K SEC Filings

Filed On	Filing
05 Feb 2025	8-K: Costs Associated with Exit or Disposal Activities; Departure/Election of Directors or Officers; Compensation +1 more
31 Jan 2025	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
24 Jan 2025	8-K: Entry into a Material Definitive Agreement; Triggering Events That Accelerate a Financial Obligation
17 Jan 2025	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
26 Dec 2024	8-K: Departure/Election of Directors or Officers; Compensation
29 Nov 2024	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
22 Nov 2024	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
13 Nov 2024	8-K: Results of Operations and Financial Condition
06 Nov 2024	8-K: Costs Associated with Exit or Disposal Activities; Departure/Election of Directors or Officers; Compensation +1 more
14 Aug 2024	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
29 Jul 2024	8-K: Costs Associated with Exit or Disposal Activities
20 Jun 2024	8-K: Submission of Matters to a Vote of Security Holders
31 May 2024	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
14 May 2024	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
09 May 2024	8-K: Results of Operations and Financial Condition
09 Apr 2024	8-K: Other Events
20 Mar 2024	8-K: Departure/Election of Directors or Officers; Compensation
07 Mar 2024	8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition
17 Nov 2023	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
09 Nov 2023	8-K: Results of Operations and Financial Condition

Comments